| http://www.w3.org/ns/prov#value | - Ischemix, a Maynard, MA-based developer of drugs intended to prevent tissue damage that occurs after heart attacks and other cardiac events, says that it has appointed board member Robert ???Duffy??? DuFresne to be its new CEO. He will replace former chief executive Reinier Beeuwkes, who is remaining president and chairman of the company.
|
